AI Stock Analysis - Astrazeneca (AZN)
Analysis generated January 12, 2026.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company primarily operates within three main therapy areas: Oncology, Cardiovascular & Renal, and Respiratory. AstraZeneca is headquartered in Cambridge, UK, and operates in over 100 countries, providing treatments for millions of patients worldwide.
Stock Alerts - Astrazeneca (AZN)
 |
Astrazeneca | January 14 Julia Letlow (member of U.S. congress) is buying shares |
|
Astrazeneca | January 13 Gilbert Cisneros (member of U.S. congress) is buying shares |
|
Astrazeneca | December 16 Gilbert Cisneros (member of U.S. congress) is buying shares |
|
Astrazeneca | November 25 Lisa McClain (member of U.S. congress) is selling shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for Astrazeneca
About Astrazeneca
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.
| Price | $95.60 |
| Target Price | Sign up |
| Volume | 6,470,000 |
| Market Cap | $288B |
| Year Range | $68.24 - $96.34 |
| Dividend Yield | 1.68% |
| PE Ratio | 30.88 |
| Analyst Rating | 100% buy |
| Earnings Date | February 10 '26 |
| Industry | Drug Manufacturers |
In the news
 |
Is There An Opportunity With AstraZeneca PLC's (LON:AZN) 46% Undervaluation?January 23 - Yahoo |
AstraZeneca PLC (AZN) Gains After Successful Saphnelo TrialJanuary 20 - Yahoo Entertainment |
|
What Makes AstraZeneca (AZN) a Strong Growing Company?January 15 - Yahoo Entertainment |
|
|
Astrazeneca (AZN) Ascends While Market Falls: Some Facts to NoteJanuary 14 - Yahoo |
 |
AstraZeneca PLC (AZN) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 13 - SeekingAlpha |
 |
Berenberg Bank Remains Bullish on AstraZeneca PLC (AZN) – Here’s WhyJanuary 10 - Yahoo Entertainment |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 15.2B | 2.86B | 12.3B | 2.53B | 5.14B | 1.190 |
| Q2 '25 | 14.5B | 2.47B | 12B | 2.45B | 4.96B | 0.790 |
| Q1 '25 | 13.6B | 2.24B | 11.3B | 2.92B | 5.04B | 1.250 |
| Q4 '24 | 14.9B | 2.73B | 12.2B | 1.5B | 2.81B | 1.050 |
| Q3 '24 | 13.6B | 3.08B | 10.5B | 1.43B | 4.1B | 1.040 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Julia Letlow |
Jan 14, 26 | Buy | $1K - $15K |
| Gilbert Cisneros |
Jan 13, 26 | Buy | $1K - $15K |
| Gilbert Cisneros |
Dec 16, 25 | Buy | $1K - $15K |
Read more about Astrazeneca (AZN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - Astrazeneca
The Market Cap of Astrazeneca is $288B.
As of today, Astrazeneca's PE (Price to Earnings) ratio is 30.88.
Astrazeneca will report its next earnings on February 10 '26.
Currently, the price of one share of Astrazeneca stock is $95.60.
The AZN stock price chart above provides a comprehensive visual representation of Astrazeneca's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Astrazeneca shares. Our platform offers an up-to-date AZN stock price chart, along with technical data analysis and alternative data insights.
Yes, Astrazeneca (AZN) offers dividends to its shareholders, with a dividend yield of 1.68%. This dividend yield represents Astrazeneca's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Astrazeneca in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of Astrazeneca are Johnson & Johnson, Eli Lilly and Company, Pfizer, AbbVie, and TherapeuticsMD.
